Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway

Acta Biochimica et Biophysica Sinica

Volumn 48, Issue 8, 2016, Pages 750-755

  Huang, Jingjia ^a   Peng, Kunjian ^a   Wang, Linghao ^a   Wen, Bin ^a   Zhou, Lin ^a   Luo, Tiao ^a   Su, Min ^a   Li, Jijia ^a   Luo, Zhiyong ^a  

^a Central South University   (China)

Author keywords

apoptosis; ginsenoside Rh2; microarray; tumor necrosis factor

Indexed keywords

CASPASE; GINSENOSIDE; GINSENOSIDE RH 2; TUMOR NECROSIS FACTOR;

APOPTOSIS; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DRUG EFFECTS; ENZYMOLOGY; HL-60 CELL LINE; HUMAN; LEUKEMIA; METABOLISM; PATHOLOGY;

APOPTOSIS; CASPASES; CELL PROLIFERATION; G1 PHASE; GINSENOSIDES; HL-60 CELLS; HUMANS; LEUKEMIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84984876753     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmw049     Document Type: Article

References (31)

1. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999, 58: 1685-1693.
2. Chang YS, Seo EK, Gyllenhaal C, Block KI. Panax ginseng: a role in cancer therapy? Integr Cancer Ther 2003, 2: 13-33.
3. Lee CH, Kim J. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 2014, 38: 161-166.
4. Li C, Qin G, Shi R, Zhang M, Lv J. Ginsenoside Rg1 reduces toxicity of PM2.5 on human umbilical vein endothelial cells by upregulating intracellular antioxidative state. Environ Toxicol Phar 2013, 35: 21-29.
5. Lee I, Hyam SR, Jang S, Han MJ, Kim D. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages. J Agr Food Chem 2012, 60: 9595-9602.
6. Wu Y, Yu Y, Szabo A, Han M, Huang XF. Central inflammation and leptin resistance are attenuated by ginsenoside Rb1 treatment in obese mice fed a high-fat diet. PLos One 2014, 9: e92618.
7. Li J, Zhong W, Wang W, Hu S, Yuan J, Zhang B, Hu T, et al. Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-kappaB activation. PLos One 2014, 9: e87810.
8. Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, Kim MJ, Kim HS, et al. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem Biophys Res Commun 2007, 364: 1002-1008.
9. Cho Y, Hur S, Kim J, Kim J, Lee D, Choe J, Won M, et al. Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation. J Biol Chem 2015, 290: 467-477.
10. Shin K, Seo C, Cho H, Oh S, Hong S, Yoo H, Hong J, et al. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells. Arch Pharm Res 2014, 37: 1183-1192.
11. Chen W, Qiu Y. Ginsenoside Rh2 targets EGFR by up-regulation of miR-491 to enhance anti-tumor activity in hepatitis B virus-related hepatocellular carcinoma. Cell Biochem Biophys 2015, 72: 325-331.
12. Zhang Y, Zhang R, Xu H, Yu X, Qu S, Sui D. 20(S)-Protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway. Am J Chin Med 2013, 41: 1137-1152.
13. Zhang Q, Hong B, Wu S, Niu T. Inhibition of prostatic cancer growth by ginsenoside Rh2. Tumor Biol 2015, 36: 2377-2381.
14. Wang J, Nao J, Zhang M, He P. 20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways. Tumor Biol 2014, 35: 11985-11994.
15. Wen X, Zhang H, Zhao L, Yao Y, Zhao J, Tang J. Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer. Asian Pac J Cancer P 2015, 16: 1105-1109.
16. Chung KS, Cho SH, Shin JS, Kim DH, Choi JH, Choi SY, Rhee YK, et al. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-expression. Carcinogenesis 2013, 34: 331-340.
17. Guo X, Guo Q, Li Y, Lee S, Wei X, Jin Y. Ginsenoside Rh2 induces human hepatoma cell apoptosisvia Bax/Bak triggered cytochrome C release and caspase-9/caspase-8 activation. Int J Mol Sci 2012, 13: 15523-15535.
18. Guan N, Huo X, Zhang Z, Zhang S, Luo J, Guo W. Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13. Tumor Biol 2015, 36: 6789-6795.
19. Tang X. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol 2013, 19: 1582.
20. An IS, An S, Kwon KJ, Kim YJ, Bae S. Ginsenoside Rh2 mediates changes in the microRNA expression profile of human non-small cell lung cancer A549 cells. Oncol Rep 2013, 29: 523-528.
21. Cheng C, Yang S, Huang C, Chen J, Chang W, Hsu S. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemoth Pharm 2005, 55: 531-540.
22. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104: 487-501.
23. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AJ. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281: 1680-1683.
24. Wang L, Du F, Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008, 133: 693-703.
25. He L, Lee J, Jang JH, Lee SH, Nan MH, Oh BC, Lee SG, et al. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-kappaB, NFATc1 and c-Fos. Bone 2012, 50: 1207-1213.
26. Xia T, Wang JC, Xu W, Xu LH, Lao CH, Ye QX, Fang JP. 20SGinsenoside Rh2 induces apoptosis in human Leukaemia Reh cells through mitochondrial signaling pathways. Biol Pharm Bull 2014, 37: 248-254.
27. Chung KS, Cho SH, Shin JS, Kim DH, Choi JH, Choi SY, Rhee YK, et al. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-beta expression. Carcinogenesis 2013, 34: 331-340.
28. Guo XX, Guo Q, Li Y, Lee SK, Wei XN, Jin YH. Ginsenoside Rh2 induces human hepatoma cell apoptosisvia bax/bak triggered cytochrome C release and caspase-9/caspase-8 activation. Int J Mol Sci 2012, 13: 15523-15535.
29. Li S, Gao Y, Ma W, Guo W, Zhou G, Cheng T, Liu Y. EGFR signalingdependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol 2014, 35: 5593-5598.
30. Li S, Guo W, Gao Y, Liu Y. Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor. Tumour Biol 2015, 36: 2607-2612.
31. Liu ZH, Li J, Xia J, Jiang R, Zuo GW, Li XP, Chen Y, et al. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells. Chem Biol Interact 2015, 242: 227-234.